Outcomes of Neoadjuvant Cemiplimab for Squamous Cell Carcinoma of the Head and Neck
This secondary analysis of a phase 2 clinical trial examines long-term survival for resectable cutaneous squamous cell carcinoma of the head and neck according to pathologic response.
Source: JAMA Otolaryngology - Head and Neck Surgery - Category: ENT & OMF Source Type: research
More News: Cancer & Oncology | Carcinoma | Clinical Trials | ENT & OMF | Neoadjuvant Therapy | Skin Cancer | Squamous Cell Carcinoma